Relapsing Multiple Sclerosis (RMS)

Also known as: Relapsed Multiple sclerosis / Multiple Sclerosis Relapse / Relapsing Multiple Sclerosis / Multiple sclerosis flare

DrugDrug NameDrug Description
DB00242CladribineA purine antimetabolite used for the management of relapsing forms of Multiple Sclerosis (MS), used in patients who have not responded to or who were unable to tolerate alternative MS drugs.
DB00111DaclizumabA monoclonal anti-CD25 antibody that blocks the interleukin-2 receptor which is used to treat relapsing forms of multiple sclerosis.
DB14783Diroximel fumarateA drug used for the treatment of relapsing forms of Multiple Sclerosis (MS).
DB11988OcrelizumabA CD20 specific monoclonal antibody used to treat relapsing remitting multiple sclerosis.
DrugDrug NameTargetType
DB00242CladribinePurine nucleoside phosphorylasetarget
DB00242CladribineDNAtarget
DB00242CladribineDeoxycytidine kinaseenzyme
DB00242CladribineRibonucleoside-diphosphate reductase large subunittarget
DB00242CladribineRibonucleoside-diphosphate reductase subunit M2target
DB00242CladribineRibonucleoside-diphosphate reductase subunit M2 Btarget
DB00242CladribineDNA polymerase alpha catalytic subunittarget
DB00242CladribineDNA polymerase epsilon catalytic subunit Atarget
DB00242CladribineDNA polymerase epsilon subunit 2target
DB00242CladribineDNA polymerase epsilon subunit 3target
DB00242CladribineDNA polymerase epsilon subunit 4target
DB00242CladribineATP-binding cassette sub-family G member 2transporter
DB00242CladribineSolute carrier family 28 member 3transporter
DB00111DaclizumabInterleukin-2 receptor subunit alphatarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
DB00111DaclizumabComplement C1r subcomponenttarget
DB00111DaclizumabComplement C1q subcomponent subunit Atarget
DB00111DaclizumabComplement C1q subcomponent subunit Btarget
DB00111DaclizumabComplement C1q subcomponent subunit Ctarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
DB00111DaclizumabHigh affinity immunoglobulin gamma Fc receptor Itarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor II-atarget
DB00111DaclizumabInterleukin-2 receptor subunit betatarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor II-btarget
DB00111DaclizumabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
DB14783Diroximel fumarateLiver esterasesenzyme
DB14783Diroximel fumarateNeuronal acetylcholine receptor subunit alpha-10target
DB11988OcrelizumabB-lymphocyte antigen CD20target
DrugDrug NamePhaseStatusCount
DB00242Cladribine1Recruiting2
DB05092CDP3231 / 2Completed1
DB06399Atacicept2Terminated2
DB00060Interferon beta-1a2Not Yet Recruiting1
DB00068Interferon beta-1b2Not Yet Recruiting1
DB06685Laquinimod2Withdrawn1
DB00108Natalizumab2Terminated1
DB06650Ofatumumab2Active Not Recruiting1
DB09122Peginterferon beta-1a2Not Yet Recruiting1
DB09145Water2Not Yet Recruiting1
DB12612Ozanimod2 / 3Completed1
DB00087Alemtuzumab3Recruiting1
DB00242Cladribine3Recruiting1
DB10583Clostridium tetani toxoid antigen (formaldehyde inactivated)3Completed1
DB10583Clostridium tetani toxoid antigen (formaldehyde inactivated)3Recruiting1
DB08868Fingolimod3Completed2
DB14999Human interferon beta3Terminated1
DB01050Ibuprofen3Completed1
DB00060Interferon beta-1a3Active Not Recruiting2
DB00060Interferon beta-1a3Completed6
DB06685Laquinimod3Terminated2
DB00788Naproxen3Completed1
DB00108Natalizumab3Recruiting1
DB11988Ocrelizumab3Active Not Recruiting3
DB11988Ocrelizumab3Recruiting1
DB06650Ofatumumab3Active Not Recruiting1
DB06650Ofatumumab3Recruiting1
DB12612Ozanimod3Completed1
DB09122Peginterferon beta-1a3Completed3
DB12016Ponesimod3Completed1
DB00073Rituximab3Recruiting2
DB08880Teriflunomide3Active Not Recruiting3
DB08880Teriflunomide3Completed1
DB08880Teriflunomide3Terminated1
DB11850Ublituximab3Active Not Recruiting2
DB11850Ublituximab3Enrolling by Invitation1
DB09145Water3Completed1
DB05299keyhole limpet hemocyanin3Recruiting1
DB08868Fingolimod4Completed1
DB00060Interferon beta-1a4Completed1
DB00060Interferon beta-1a4Withdrawn1
DB00068Interferon beta-1b4Withdrawn1
DB00108Natalizumab4Terminated1
DB09122Peginterferon beta-1a4Withdrawn1
DB08880Teriflunomide4Recruiting1
DB00060Interferon beta-1aNot AvailableActive Not Recruiting1
DB00060Interferon beta-1aNot AvailableCompleted1
DB00108NatalizumabNot AvailableCompleted1